Intraperitoneal and Intravenous Paclitaxel Chemotherapy With Oral Capecitabine for Gastric Adenocarcinoma With Peritoneal Carcinomatosis
Clinical trial NCT04034251 · TERMINATED
Trial details
- NCT number
- NCT04034251
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-09
- Primary completion
- 2023-02-25
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.